Investment
Features
FeesSafety
Academy
More
Pluang+

India's gold demand stays strong despite price swings; ETF inflows and futures trading rise in August.

Market News
18 Sep 2026
Kitco
View Source
Neutral
India's gold demand stays strong despite price swings; ETF inflows and futures trading rise in August.

In August, India's gold market showed resilience with steady jewelry buying and physical investment demand despite volatile gold prices. Domestic gold prices rose 12% in August but pulled back in September amid changing Fed policy expectations. Gold ETFs saw a 67% increase in inflows, and gold futures trading hit a five-month high, reflecting strong investor interest. However, imports dropped sharply, indicating sufficient local supply. The World Gold Council expects demand to improve during the festive and wedding season, though high prices may limit discretionary purchases.

India's gold market during its festive season provides context for Pluang's market snapshot as of Sep 18, 2026 21:35 WIB: Among 150 US stocks priced on Pluang, 37 rose and 112 fell. Applied Materials, Inc. (AMAT) gained 3.45% with a strong 98% buy order activity and a typical hold time of 66 days, contrasting with Gold Fields Limited (GFI), which declined 3.12% and saw a nearly balanced order activity of 47% sell and 53% buy, held typically for 48 days. Accenture plc (ACN) dropped 3.50%, held for 131 days on average.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
2 hours ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
3 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
3 hours ago
Micron unveils a 512GB memory module validated by AMD and Intel, but revenue impact is two years away.

Micron unveils a 512GB memory module validated by AMD and Intel, but revenue impact is two years away.

Micron has developed a 512GB server memory module that replaces four 128GB modules, with validation from AMD and Intel for future platforms. This innovation is significant but will not generate revenue until the second half of 2027, meaning it won't ...

Market News
Bullish
4 hours ago
Intapp partners with OpenAI; Boot Barn, Costco, and DoorDash show mixed growth and valuation signals.

Intapp partners with OpenAI; Boot Barn, Costco, and DoorDash show mixed growth and valuation signals.

Intapp (INTA) gained nearly 1.5% pre-market after announcing a new partnership with OpenAI, supported by improving fundamentals and positive analyst revisions despite recent stock volatility. Boot Barn (BOOT) holds a positive outlook with strong forw...

Analyst Insights
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App